首页> 外文期刊>Gut and Liver >Silencing of CXCR4 Inhibits Tumor Cell Proliferation and Neural Invasion in Human Hilar Cholangiocarcinoma
【24h】

Silencing of CXCR4 Inhibits Tumor Cell Proliferation and Neural Invasion in Human Hilar Cholangiocarcinoma

机译:CXCR4沉默抑制人肝门胆管癌的肿瘤细胞增殖和神经侵袭。

获取原文
获取外文期刊封面目录资料

摘要

Background/AimsTo evaluate the expression of CXC motif chemokine receptor 4 (CXCR4) in the tissues of patients with hilar cholangiocarcinoma (hilar-CCA) and to investigate the cell proliferation and frequency of neural invasion (NI) influenced by RNAi-mediated CXCR4 silencing.MethodsAn immunohistochemical technique was used to detect the expression of CXCR4 in 41 clinical tissues, including hilar-CCA, cholangitis, and normal bile duct tissues. The effects of small interference RNA (siRNA)-mediated CXCR4 silencing were detected in the hilar-CCA cell line QBC939. Cell proliferation was determined by MTT. Expression of CXCR4 was monitored by quantitative real time polymerase chain reaction and Western blot analysis. The NI ability of hilar-CCA cells was evaluated using a perineural cell and hilar-CCA cell coculture migration assay.ResultsThe expression of CXCR4 was significantly induced in clinical hilar-CCA tissue. There was a positive correlation between the expression of CXCR4 and lymph node metastasis/NI in hilar-CCA patients (p<0.05). Silencing of CXCR4 in tumor cell lines by siRNA led to significantly decreased NI (p<0.05) and slightly decreased cell proliferation.ConclusionsCXCR4 is likely correlated with clinical recurrence of hilar-CCA. CXCR4 is involved in the invasion and proliferation of human hilar-CCA cell line QBC939, indicating that CXCR4 could be a promising therapeutic target for hilar-CCA.
机译:背景/目的评估CXC基序趋化因子受体4(CXCR4)在肝门胆管癌(hilar-CCA)患者组织中的表达,并研究RNAi介导的CXCR4沉默影响细胞增殖和神经侵袭(NI)的频率。方法采用免疫组化技术检测CXCR4在41例肝门CCA,胆管炎和正常胆管组织中的表达。在肝门-CCA细胞系QBC939中检测到小干扰RNA(siRNA)介导的CXCR4沉默的影响。细胞增殖通过MTT确定。通过定量实时聚合酶链反应和蛋白质印迹分析监测CXCR4的表达。应用神经周细胞和肺门-CCA细胞共培养迁移实验评估了肺门-CCA细胞的NI能力。肺门CCA患者的CXCR4表达与淋巴结转移/ NI呈正相关(p <0.05)。 siRNA沉默肿瘤细胞系中的CXCR4可导致NI显着降低(p <0.05)和细胞增殖略有降低。结论CXCR4可能与肺门CCA的临床复发有关。 CXCR4参与人类肺门-CCA细胞系QBC939的侵袭和增殖,这表明CXCR4可能成为有希望的肝门-CCA治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号